You are here

  • Home
  • Archive
  • Volume 34, Issue 7
  • Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study

Article metrics

Article menu

Download PDFPDF

Original research
Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study

 

Online download statistics by month:

Online download statistics by month: July 2024 to November 2024

AbstractFullPdf
Jul 202410611052387
Aug 2024295294113
Sep 2024238233109
Oct 202417016284
Nov 202417016986
Total19341910779